Showing results (201-210 of 623) with videos related to

Sort By:
Pageof 63
Leukemia & Lymphoma|July 1, 1997
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrenceE Orlandi, M Lazzarino, E Brusamolino, et al.
Journal of Molecular and Cellular Cardiology|January 1, 1991
Preserving effect of fructose-1,6-bisphosphate on high-energy phosphate compounds during anoxia and reperfusion in isolated langendorff-perfused rat heartsG Lazzarino, M E Nuutinen, B Tavazzi, et al.
Haematologica|January 1, 1989
Hemorrhagic and thrombotic complications in polycythemia vera. A clinical studyE Orlandi, G Castelli, E Brusamolino, et al.
Psychological Medicine|August 22, 2023
Temporal patterns in the recorded annual incidence of common mental disorders over two decades in the United Kingdom: a primary care cohort studyJ Dykxhoorn, D Osborn, K Walters, et al.
International Journal of Molecular Sciences|August 12, 2022
ILB®, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain InjuryGiacomo Lazzarino, Valentina Di Pietro, Marco Rinaudo, et al.
American Journal of Clinical Oncology|February 1, 1986
Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemiaM Lazzarino, E Morra, E Brusamolino, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1989
Arctic life adaptation--III. The function of whale (Balaenoptera acutorostrata) hemoglobinO Brix, S G Condò, G Lazzarino, et al.
Journal of Microscopy|January 13, 2011
Atomic force microscopy investigation of morphological changes in living keratinocytes treated with HgCl(2) at not cytotoxic dosesM Lasalvia, G Perna, E Mezzenga, et al.
Stem Cells and Development|September 15, 2010
Fragmentation as a mechanism for growth cone pruning and degenerationJelena Ban, Elisa Migliorini, Valentina Di Foggia, et al.
Haematologica|July 1, 1990
CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's diseaseE Brusamolino, G Castelli, G Pagnucco, et al.
Pageof 63